DOI QR코드

DOI QR Code

Transradial versus transfemoral intervention in ST-segment elevation myocardial infarction patients in Korean population

  • Li, Hu (Department of Cardiovascular, The Second Affiliated Hospital of Kunming Medical University) ;
  • Rha, Seung-Woon (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Choi, Byoung Geol (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Shim, Min Suk (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Choi, Se Yeon (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Choi, Cheol Ung (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Kim, Eung Ju (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Oh, Dong Joo (Department of Medicine, Graduate School, Korea University College of Medicine) ;
  • Cho, Byung Ryul (Department of Cardiology, Kangwon National University Hospital) ;
  • Kim, Moo Hyun (Cardiovascular Center, Dong-A University Hospital) ;
  • Kim, Doo-Il (Cardiovascular Center, Inje University Busan Paik Hospital) ;
  • Jeong, Myung-Ho (Cardiovascular Center, Chonnam National University Hospital) ;
  • Yoo, Sang Yong (Cardiovascular Center, Gangneung Asan Hospital, University of Ulsan College of Medicine) ;
  • Jeong, Sang-Sik (Cardiovascular Center, Gangneung Asan Hospital, University of Ulsan College of Medicine) ;
  • Kim, Byung Ok (Cardiovascular Center, Inje University Sanggye Paik Hospital) ;
  • Hyun, Min Su (Cardiovascular Center, Soonchunhyang University Seoul Hospital) ;
  • Youn, Young-Jin (Cardiovascular Center, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Yoon, Junghan (Cardiovascular Center, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine)
  • Received : 2016.09.30
  • Accepted : 2017.01.09
  • Published : 2018.07.01

Abstract

Background/Aims: Transradial intervention (TRI) is becoming the preferred method over transfemoral intervention (TFI) because TRI is associated with lower incidence of major bleeding and vascular complications. However, there has been limited published data regarding the clinical outcomes of TRI versus TFI in Korean patients with ST-elevation myocardial infarction (STEMI). Methods: A total of 689 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) from January to December of 2009 at nine university hospitals were enrolled in this study. Mid-term angiographic and 12-month cumulative clinical outcomes of the TRI group (n = 220, 31.9%) were compared to those of the TFI group (n = 469, 28.1%). Results: After propensity score matching, in-hospital complications and the 12-month major clinical outcomes during follow-up in the two groups were similar to each other. However, the incidence rates of repeat revascularization (6.4% vs. 0.5%, p = 0.003), target vessel revascularization (6.4% vs. 0.5%, p = 0.003), and major adverse cardiac events (MACE; 11.6% vs. 4.6%, p = 0.018) in the TFI group were higher than those in the TRI group during the 12-month of follow-up. Conclusions: In our study, TRI in STEMI patients undergoing primary PCI with DESs was associated with lower incidence of access site hematoma, 12-month repeat revascularization, and MACE compared to TFI. Therefore, TRI might play an important role in reducing bleeding complications while improving major clinical outcomes in STEMI patients undergoing primary PCI with DESs.

Keywords

References

  1. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-356. https://doi.org/10.1016/j.jacc.2004.04.034
  2. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-140. https://doi.org/10.1016/j.ahj.2008.08.023
  3. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-935. https://doi.org/10.1016/S0002-9149(03)00972-X
  4. Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007;69:961-966. https://doi.org/10.1002/ccd.21087
  5. Oweida SW, Roubin GS, Smith RB 3rd, Salam AA. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg 1990;12:310-315. https://doi.org/10.1016/0741-5214(90)90153-2
  6. Nasser TK, Mohler ER 3rd, Wilensky RL, Hathaway DR. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 1995;18:609-614. https://doi.org/10.1002/clc.4960181105
  7. Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011;307:1409-1420.
  8. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123:2736-2747. https://doi.org/10.1161/CIRCULATIONAHA.110.009449
  9. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351. https://doi.org/10.1161/CIRCULATIONAHA.106.685313
  10. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-1275. https://doi.org/10.1016/S0735-1097(97)00064-8
  11. Delarche N, Idir M, Estrade G, Leblay M. Direct angioplasty for acute myocardial infarction in elderly patients using transradial approach. Am J Geriatr Cardiol 1999;8:32-35.
  12. Cooper CJ, El-Shiekh RA, Cohen DJ, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison. Am Heart J 1999;138:430-436. https://doi.org/10.1016/S0002-8703(99)70143-2
  13. Mehta SR, Jolly SS, Cairns J, et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol 2012;60:2490-2499. https://doi.org/10.1016/j.jacc.2012.07.050
  14. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012;60:2481-2489. https://doi.org/10.1016/j.jacc.2012.06.017
  15. Byrne RA, Cassese S, Linhardt M, Kastrati A. Vascular access and closure in coronary angiography and percutaneous intervention. Nat Rev Cardiol 2013;10:27-40. https://doi.org/10.1038/nrcardio.2012.160
  16. Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv 2003;59:26-33. https://doi.org/10.1002/ccd.10493
  17. Ellis SG, Miller DP, Brown KJ, et al. In-hospital cost of percutaneous coronary revascularization: critical determinants and implications. Circulation 1995;92:741-747. https://doi.org/10.1161/01.CIR.92.4.741
  18. Wolfe MW, Roubin GS, Schweiger M, et al. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: clinical and procedural predictors. Heparin Registry Investigators. Circulation 1995;92:311-319. https://doi.org/10.1161/01.CIR.92.3.311
  19. Bernat I, Horak D, Stasek J, et al. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol 2014;63:964-972. https://doi.org/10.1016/j.jacc.2013.08.1651
  20. Jolly SS, Cairns J, Niemela K, et al. Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial. JACC Cardiovasc Interv 2013;6:258-266. https://doi.org/10.1016/j.jcin.2012.10.016

Cited by

  1. Outcomes of Transradial Versus Transfemoral Access of Percutaneous Coronary Intervention in STEMI: Systematic Review and Updated Meta-analysis vol.19, pp.5, 2018, https://doi.org/10.1080/14779072.2021.1915768